Revlimid (lenalidomide) is a brand-name oral capsule that’s prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...

Doctors prescribe Revlimid (lenalidomide) to treat certain blood cancers, including multiple myeloma, mantle cell lymphoma, and others. The drug is not safe to take while pregnant, and doctors avoid ...

The FDA has approved a new drug called Revlimid to treat a type of the rare blood disorder, myelodysplastic syndrome (MDS), which can progress to become leukemia. Revlimid treats a type of MDS ...

Revlimid (lenalidomide) is a brand-name drug that doctors may prescribe to treat certain cancers of the blood. If a person has a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) ...

Maintenance Revlimid was shown to improve overall survival in patients with multiple myeloma. Patients with multiple myeloma saw a 26 percent decrease in risk of death when they took maintenance ...

The combination of Revlimid with dexamethasone, previously approved for treatment in patients with multiple myeloma who received at least 1 prior treatment, has received FDA approval for use in newly ...

Dr. Reddy’s licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March 2022 date previously granted to Natco Dr. Reddy’s also licensed ...

On a busy morning after Bristol Myers Squibb revealed that the FDA approved its potential blockbuster Camzyos, the pharma giant also introduced negative news about a fading blockbuster. Sales of ...

When Bristol Myers Squibb agreed to buy Celgene for $74 billion last year, analysts wondered if it was worth the price—and they specifically called out patent challenges to Celgene's top-selling ...

On May 7, 2015, the European Patent Office (EPO) revoked one of Celgene's ( CELG) patents on Revlimid®. Revlimid® reportedly accounts for almost $5 billion of Celgene's nearly $7.5 billion in annual ...

Cipla licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after March 2022 Cipla also licensed to sell generic lenalidomide in the U.S. without ...